SCHEMBL7231693

SCHEMBL7231693

CC(=O)N[C@@H](CC(C)C)[C@@H]1O[C@@H](C(=O)O)C[C@H]1c1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231092 0.87 POLB (0.33) —
SCHEMBL7231142 0.79 — —
Hydrochloric Acid SCHEMBL7231930 0.78 — —
SCHEMBL7170130 0.78 — —
SCHEMBL6694301 0.78 — —
Hydrochloric Acid SCHEMBL6698994 0.78 — —
SCHEMBL7829651 0.74 ALDH1A1 (0.38) —
SCHEMBL7230182 0.71 POLB (0.34) —
SCHEMBL7232763 0.71 POLB (0.34) —
SCHEMBL4321037 0.70 CYP1A2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518305-B1 For inhibiting neuraminidases from disease- causing microorganisms, especially, influenza neuraminidase ABBOTT LABORATORIES 2003-02-11 — — US claimed
US-6518305-B1 For inhibiting neuraminidases from disease- causing microorganisms, especially, influenza neuraminidase ABBOTT LABORATORIES 2003-02-11 — — US disclosed
Send feedback